French Drug Regulator Under Investigation

French magistrates looking into whether a diabetes drug caused deaths have put the country's drug-safety agency ANSM under formal investigation for alleged involuntary manslaughter.
March 22, 2013

French magistrates looking into whether a diabetes drug caused deaths have put the country's drug-safety agency ANSM under formal investigation for alleged involuntary manslaughter, widening their criminal probe beyond the French company that developed and sold the medication.

The investigating magistrates are seeking to determine whether the agency neglected multiple alerts over a 14-year period that Mediator, a drug made by French company Servier, was potentially dangerous, a spokeswoman for the Paris prosecutors' office said Wednesday. Read the full story.

About the Author

Mimosa Spencer

The Wall Street Journal

Sign up for Pharma Manufacturing Newsletters
Get the latest news and updates